Protective effect of coptisine free base on indomethacin-induced gastric ulcers in rats: Characterization of potential molecular mechanisms

Life Sci. 2018 Jan 15:193:47-56. doi: 10.1016/j.lfs.2017.12.004. Epub 2017 Dec 6.

Abstract

Aims: The aim of this study was to comparatively investigate the potential gastroprotective effect and underlying mechanisms of coptisine free base (CFB, 8-hydroxy-7, 8-dihydrocoptisine), berberine and lansoprazole against indomethacin-induced gastric ulcer in rats.

Materials and methods: CFB (10, 20 and 40mg/kg), berberine (20mg/kg) and lansoprazole (30mg/kg) were orally administrated to rats prior to indometacin ingestion, and gastric lesions were evaluated macroscopically and histologically, and further analyzed by ELISA, qRT-PCR and Western blot.

Key findings: CFB exerted comparable or superior gastroprotective effect to berberine in protecting against indomethacin-induced gastric injury. CFB pretreatment significantly enhanced the levels of superoxide dismutase (SOD) and glutathione (GSH), and markedly decreased the malonaldehyde (MDA) content. CFB administration effectively suppressed the levels of myeloperoxidase (MPO), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and angiotensin II (Ang II). Besides, CFB substantially up-regulated the mRNA expressions of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), and promoted gastric mucosal prostaglandin E2 level (PGE2). Furthermore, CFB pretreatment remarkably increased the translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) from cytosol into the nucleus, and the expression of heme oxygenase-1 (HO-1), while significantly decreased the expression of mitogen activated protein Kinase Kinase 6 (MKK6) and translocation of p38 mitogen-activated protein kinase (p38 MAPK).

Significance: This was the first investigation reporting the anti-ulcer effect of protoberberine alkaloid free base on in vivo rodent model. The gastroprotective mechanism of CFB might involve favorable regulation of antioxidant and anti-inflammatory status mediated, at least partially, by the Nrf2 signaling pathway and p38 MAPK translocation.

Keywords: Anti-inflammatory; Antioxidant; Coptisine free base; Gastroprotective action; Nrf2; p38 MAPK.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / pharmacology
  • Berberine / analogs & derivatives*
  • Berberine / metabolism
  • Berberine / pharmacology
  • Berberine / therapeutic use
  • Cyclooxygenase 1 / metabolism
  • Cyclooxygenase 2 / metabolism
  • Disease Models, Animal
  • Gastric Mucosa / pathology
  • Indomethacin
  • Interleukin-1beta / metabolism
  • Lansoprazole / pharmacology
  • Lansoprazole / therapeutic use
  • Male
  • Rats
  • Stomach Ulcer / drug therapy*
  • Stomach Ulcer / pathology
  • Superoxide Dismutase / metabolism
  • Tumor Necrosis Factor-alpha / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Interleukin-1beta
  • Tumor Necrosis Factor-alpha
  • coptisine
  • Berberine
  • Lansoprazole
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Superoxide Dismutase
  • p38 Mitogen-Activated Protein Kinases
  • Indomethacin